Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents

NCT02216552 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

NAFLD
TYPE 2 DIABETES
METABOLIC SYNDROME

Interventions

DIETARY_SUPPLEMENT: Resveratrol
DIETARY_SUPPLEMENT: Placebo

Sponsor

University of Manitoba

Collaborators

[object Object]